News & Updates
Filter by Specialty:
Post-COVID-19 vax uveitis may be more common in Southeast Asia
COVID-19 vaccination-induced uveitis is uncommon, with cases mostly self-limiting and showing good responses to treatment with no long-term sequelae, according to a Singapore study. However, reactivation of such infections appears to occur at a higher proportion in Southeast Asia, where viral and toxoplasma infections are more common.
Post-COVID-19 vax uveitis may be more common in Southeast Asia
25 Jul 2022
Local landscape, air pollution tied to COVID-19 death risk
Urban environmental determinants of vitamin D status, such as air pollution and sun exposure, appear to be important factors in assessing the risk of mortality from COVID-19, reports a recent study.
Local landscape, air pollution tied to COVID-19 death risk
24 Jul 2022
20-µg hep B vaccine can prevent vertical transmission
Using a 20-µg dose to vaccinate children born to mothers with detectable levels of hepatitis B virus surface antigen (HBsAg) appears to avert vertical transmission, reports a recent China study.
20-µg hep B vaccine can prevent vertical transmission
23 Jul 2022
HCV treatment helps prevent cirrhosis, death in persons who inject drugs
People who inject drugs (PWID) and are receiving treatment for hepatitis C virus (HCV) show a substantial decline in liver disease and mortality, according to a study.
HCV treatment helps prevent cirrhosis, death in persons who inject drugs
22 Jul 2022
40 COVID-19 vaccines and counting: Do we still need more?
There are currently 40 approved vaccines against COVID-19, of which 11 have been granted Emergency Use Authorization by the World Health Organization. [covid19.trackvaccines.org/vaccines/approved] With over 300 other candidates in the development pipeline – over 100 of which are in clinical testing [vac-lshtm.shinyapps.io/ncov_vaccine_landscape] – are new vaccines necessary?
40 COVID-19 vaccines and counting: Do we still need more?
22 Jul 2022
Investigational nitric oxide gel for water warts scores high in phase III trial
A novel nitric oxide-releasing gel, berdazimer 10.3%, proves effective in the treatment of patients with water warts or molluscum contagiosum skin infection, facilitating clearance of lesions with low adverse event rates, as shown in the phase III B-SIMPLE4 trial.
Investigational nitric oxide gel for water warts scores high in phase III trial
21 Jul 2022
Women hospitalized with COVID-19 suffer from menstrual changes, worse mental health
COVID-19 appears to alter the menstrual cycle and impair mental health in women hospitalized for the disease, a recent study has found.
Women hospitalized with COVID-19 suffer from menstrual changes, worse mental health
21 Jul 2022
Unexplained hepatitis outbreak in kids: Are COVID-19, adenovirus the triggers?
Cases of acute, severe hepatitis of unknown aetiology in young children have increased recently and investigations are underway, says an expert during a media briefing at ILC 2022.